The research program of Ravi Goyal, MD, PhD, MBA, FAHA investigates how prenatal and early-life exposures program maternal and offspring cardiovascular disease — using molecular epigenetics, vascular physiology, and computational modeling to identify mechanisms that can be modified before symptoms appear.
Research program
How do environmental exposures during fetal and early-postnatal life — hypoxia, undernutrition, environmental toxicants, maternal stress — reshape the developing cardiovascular system, and how do those changes lie dormant for decades before manifesting as adult disease?
The Goyal Laboratory approaches this question at three levels. At the molecular level, we map the epigenetic modifications — DNA methylation, histone marks, non-coding RNAs — that translate transient exposures into persistent transcriptional programs. At the tissue level, we characterize the resulting changes in vascular reactivity, contractile protein expression, and endothelial function across the maternal and fetal circulations. At the systems level, we use computational physiology and digital-twin modeling to predict how molecular-level perturbations cascade into clinically observable phenotypes.
This integrated approach is designed to identify intervention windows — moments in development when a modifiable exposure could redirect disease trajectory. The end goal is translational: tools clinicians can use to screen, stratify, and intervene before silent biology becomes overt disease.
How prenatal hypoxia, undernutrition, and environmental exposures reprogram vascular smooth muscle and endothelial function — driving lifelong hypertension and preeclampsia risk in subsequent generations.
DNA methylation, histone modifications, and non-coding RNA networks that translate early exposures into persistent transcriptional reprogramming — including identification of intervention points.
How the maternal cardiovascular system adapts to pregnancy, and how prior adverse exposures disrupt that adaptation — relevant to preeclampsia, IUGR, and recurrent pregnancy loss.
Multiscale modeling, digital twins, and clinical decision-support tools that translate bench observations into bedside applications — exemplified by the PPHrisk and EndoTwin-W platforms.
Active research funding
Active and recent extramural grants — over $14 million in direct NIH PI funding across NICHD, NIDDK, NHLBI, and NIH Office of the Director portfolios.
Investigates how prenatal environmental exposures alter the maternal vasculature and contribute to hypertensive disorders in subsequent pregnancies. Uses ovine and rodent models, ex vivo vessel physiology, and methylome profiling to identify mechanisms linking exposure history to gestational outcomes.
Small-grant mechanism supporting mechanistic studies on how DNA-methylation patterns laid down in utero shape vascular reactivity across the life course.
Multi-PI program investigating how early-life metabolic environment shapes renal structure and function. Co-Investigator role contributing developmental physiology and epigenetics expertise.
NIH Office-of-the-Director–funded collaborative program; Goyal Laboratory contributes vascular developmental physiology expertise.
Additional applications under review at NIH (NICHD, NHLBI) and DoD (CDMRP). For the complete grant history, see the lab director's CV.
Publications
More than 55 peer-reviewed publications since 2007, spanning Physiological Reviews, Hypertension Research, Physiological Genomics, Reproductive Sciences, PLoS ONE, and other journals.
Methods and capabilities
Ovine and murine pregnancy models with controlled prenatal exposure paradigms — hypoxia, undernutrition, environmental toxicants.
Wire myography, pressure myography, organ-bath preparations on intact and dissected vessels from maternal and fetal circulations.
Bulk and single-cell RNA-seq, methylome profiling (RRBS, WGBS), ChIP-seq, ATAC-seq, qPCR, Western blotting.
Differential expression, methylation analysis, pathway enrichment, network reconstruction, integration with public datasets.
Multiscale modeling of vascular function, digital-twin frameworks, decision-support algorithm development.
From bench data to deployed clinical tools — exemplified by the PPHrisk decision-support calculator and the EndoTwin-W digital twin.
Training and mentorship
The laboratory trains graduate students, postdoctoral fellows, medical students, and OB/GYN residents in rigorous translational research. Trainees develop expertise across the full experimental spectrum — from molecular technique to physiological measurement to computational analysis.
Dr. Goyal previously served as Director of Graduate Studies and currently sits on dissertation committees across multiple University of Arizona programs, including Physiological Sciences, Cellular and Molecular Medicine, and Clinical Translational Sciences.
Inquiries: rgoyal@epigenuity.com
Scientific service
Dr. Goyal has served on more than 15 NIH study sections and AHA review panels, as a peer reviewer for 30+ international journals, and as an external reviewer for the Swiss National Science Foundation. Editorial roles include past appointments to Frontiers in Reproductive Sciences, Frontiers of Epigenomics, and others. He is a Fellow of the American Heart Association (FAHA) and a member of the American Physiological Society and the Society for Reproductive Investigation.
Contact
For collaborations, trainee inquiries, peer review requests, or media — please use the appropriate channel.